Lotus Eye Hospital and Institute Limited has informed the Exchange about Copy of Newspaper Publication
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital has filed copies of its unaudited financial results for Q3 FY26 and nine months ended December 31, 2025, published in Business Standard and Tamil Hindu on February 12, 2026, as required under SEBI's Listing Regulations. Total income for Q3 FY26 stood at Rs 1,378.51 lakhs, up about 10.6% year-on-year from Rs 1,246.77 lakhs in Q3 FY25, with 9M FY26 revenue at Rs 4,079.89 lakhs versus Rs 3,884.14 lakhs in 9M FY25. However, the company slipped into a net loss of Rs 26.07 lakhs in Q3 FY26, compared with a profit of Rs 11.58 lakhs in the previous quarter. For 9M FY26, net profit fell to Rs 39.99 lakhs from Rs 48.69 lakhs a year earlier, and EPS dropped to Rs 0.19 from Rs 0.23.
Top-line growth is a positive sign, but the swing to a quarterly loss and the nearly 18% drop in nine-month profit suggest margin pressure, which may temper investor enthusiasm. The stock could see a muted or negative reaction given weakening profitability despite higher revenues.